Cardiologists Plot Next Moves After New Board Rejected
The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.
Especially given its impact on cardiology, the WHI should be the “pride” of the US, not on the chopping block, says Martha Gulati.
It’s no surprise that complications can vex concomitant procedures. But when staged, should PCI or TAVI come first?
Complications weren’t more common when leads were extracted. Yet there’s also the option of “jailing” leads instead.
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
Mamas Mamas sits down with Raj Makkar to discuss new data on the treatment of aortic regurgitation.
SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.
Especially given its impact on cardiology, the WHI should be the “pride” of the US, not on the chopping block, says Martha Gulati.
In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.
Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating statins.